Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Insmed (INSM) Stock Price Prediction and News Highlight
Fri. Nov 21, 2025

The biopharmaceutical industry is witnessing significant innovation, particularly highlighted by Insmed's introduction of BRINSUPRI, a first-in-class treatment, and the successful clinical trial results for its lung disease drug. These advancements underscore the company's commitment to developing targeted therapies for serious health conditions. The focus on effective product development is crucial for addressing the unmet needs of patients and improving health outcomes. However, challenges in regulatory approvals and market competition could impact future growth.

The price action of Insmed (INSM) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for INSM since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at 0 on 2025-11-21. The forces of and () will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), Sentiment towards Fundamentals (2.4), and Valuation Sentiment (2.9) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-02-18 10:00, EPS: $-6.19, P/E: -32.11

INSM
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-11-210%(0%)    0    0%    0.9          2.4    -1   
2025-11-200%(0%)    0    0%    0.9          3    -1   
2025-11-190%(0%)    0    0%    0.6          3.4    -1   
2025-11-180%(0%)    0    0%    0.8          2.9    -1   
2025-11-170%(0%)    0    0%    0.9          2.2    -1   
2025-11-160%(0%)    0    0%    0.8          2.2    -1   
2025-11-150%(0%)    0    0%    0.8          2.6    -1   
2025-11-140%(0%)    0    0%    0.8          2.6    -1   
2025-11-130%(0%)    0    0%    0.8          2.9    -1   
2025-11-120%(0%)    0    0%    0.5          1    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-11-21 17:11:21 Recent trades suggest a nuanced perspective on investor confidence in Insmed's future growth and investment attractiveness.
2025-11-21 17:11:21 Potential regulatory developments affecting Insmed's operations could impact investor perceptions and stock stability.
2025-11-21 17:11:21 Investor reactions to stock trades and performance metrics indicate a cautious sentiment towards Insmed's current market valuation.
2025-11-21 17:11:21 The sale of shares by Representative Gilbert Ray Cisneros, Jr. raises concerns regarding the confidence of company leaders in the stock.
2025-11-21 17:11:21 Recent fluctuations in Insmed's stock price reflect broader market concerns and investor sentiment.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA